Alfuzosin
- Molecular formula
- C19H27N5O2
- CAS Number
- 81403-68-1
- IUPAC Name
- 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine
- Molecular Weight
- 389.47g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.3000g/cm3
- Synonyms
- QUINAZOSIN
Identification
Interesting Facts About 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine
This fascinating compound belongs to the class of quinazoline derivatives, which are known for their diverse biological activities. The structure of 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine showcases a remarkable interplay between its various functional groups, which contributes to its potential therapeutic properties.
Biological Significance
Quinazoline derivatives have attracted considerable interest in medicinal chemistry due to their potential as:
- Anticancer Agents: Many quinazoline compounds have demonstrated significant activity against various cancer cell lines.
- Antiparasitic Activity: Some structures show promise in inhibiting parasite growth, making them candidates for treating diseases like malaria.
- Neurological Effects: The allylpiperazine moiety may enhance the compound's ability to interact with neurotransmitter systems, suggesting potential applications in neurology.
Chemical Relationships
The presence of methoxy groups is noteworthy as they can influence the compound's solubility and overall biological activity. Methoxy groups often enhance the electron-donating properties of aromatic systems, potentially increasing binding affinity to biological targets.
Research Implications
With ongoing research, this compound stands as a reminder of the importance of structure-activity relationships (SAR) in drug design. Scientists constantly seek to optimize these properties through:
- Modifications of functional groups to improve efficacy and reduce side effects.
- Synthetic pathways that aim for more sustainable and cost-effective production.
As with many compounds in medicinal chemistry, the journey from laboratory synthesis to clinical application can be long and complex. However, with its unique structural features, 2-(4-allylpiperazin-1-yl)-6,7-dimethoxy-quinazolin-4-amine represents a promising candidate for future advances in drug discovery.